NEW YORK (GenomeWeb News) – Bruker has priced a secondary offering of 13 million common shares at $9.85 per share.

The firm announced last week that it had filed for a secondary offering of 12 million shares of common stock by two members of the Laukien family — Marc Laukien and Isolde Laukien-Kleiner — not involved in the firm's business. Bruker will not receive any of the proceeds from the sale of shares by these two Laukien family members.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.